- UroToday Home
- Urologic Oncology
The Latest Renal Cancer Research
Recent Abstracts
-
Interpreting nephrometry scores with three-dimensional virtual modelling for better planning of robotic partial nephrectomy and predicting complications.Renal CancerSeptember 21, 2021
-
Dynamic contrast-enhanced CT-derived blood flow measurements enable early prediction of long term outcome in metastatic renal cell cancer patients on antiangiogenic treatment.Renal CancerSeptember 21, 2021
-
Treatment Options for De Novo Metastatic Clear-cell Renal Cell Carcinoma: Current Recommendations and Future Insights.Renal CancerSeptember 20, 2021
-
CT and MRI findings of cystic renal cell carcinoma: comparison with cystic collecting duct carcinoma.Renal CancerSeptember 17, 2021
-
Biomarker Screening and Prognostic Significance Analysis for Renal Cell Carcinoma.Renal CancerSeptember 17, 2021
-
Sequential immune-targeted surgical therapy resulted in disease-free survival in a case with advanced renal cell carcinoma.Renal CancerSeptember 16, 2021
-
Renal Tumor Biopsy: Rationale to Avoid Surgery in Small Renal Masses.Renal CancerSeptember 16, 2021
-
Conditional survival of metastatic clear cell renal cell carcinoma: How prognosis evolves after cytoreductive surgery of primary tumor.Renal CancerSeptember 15, 2021
-
The prognosis and clinicopathological features of different distant metastases patterns in renal cell carcinoma: analysis based on the SEER database.Renal CancerSeptember 14, 2021
-
Integrated mRNA and miRNA Transcriptomic Analyses Reveals Divergent Mechanisms of Sunitinib Resistance in Clear Cell Renal Cell Carcinoma (ccRCC).Renal CancerSeptember 14, 2021
Beyond the Abstracts
-
Efficacy of Immune-Checkpoint Inhibitors (ICI) in the Treatment of Older Adults with Metastatic Renal Cell Carcinoma (mRCC) – an International mRCC Database Consortium (IMDC) Analysis - Beyond the AbstractRenal CancerSeptember 21, 2021
-
Gene Expression Signature Correlates with Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with Everolimus Alone or with a Vascular Disrupting Agent - Beyond the AbstractRenal CancerSeptember 21, 2021
-
TRIM63 Is a Sensitive and Specific Biomarker for MiT Family Aberration-Associated Renal Cell Carcinoma - Beyond the AbstractRenal CancerAugust 5, 2021
-
PBRM1 Deficiency Confers Synthetic Lethality to DNA Repair Inhibitors in Cancer - Beyond the AbstractRenal CancerJuly 28, 2021
-
Irreversible Electroporation for the Treatment of Small Renal Masses: 5-Year Outcomes - Beyond the AbstractRenal CancerJuly 22, 2021
-
Selective Suturing or Sutureless Technique in Robot-assisted Partial Nephrectomy: Results from a Propensity-score Matched Analysis - Beyond the AbstractRenal CancerJuly 19, 2021
-
Pegilodecakin for Metastatic Renal Cell Carcinoma - Beyond the AbstractRenal CancerJune 24, 2021
-
Does Reduced Renal Function Predispose to Cancer-specific Mortality from Renal Cell Carcinoma? - Beyond the AbstractRenal CancerJune 17, 2021
-
Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-Institutional Registry (REMARCC) - Beyond the AbstractRenal CancerMay 18, 2021
-
Race/Ethnicity Determines Life Expectancy in Surgically Treated T1aN0M0 Renal Cell Carcinoma Patients - Beyond the AbstractRenal CancerMay 11, 2021